Cocrystal Pharma Inc.

Cocrystal Pharma, Inc. (Nasdaq: COCP) is a clinical-stage company developing novel, potent, broad-spectrum antiviral therapeutics to combat some of the most serious diseases facing humanity: coronaviruses (including SARS-CoV-2 and variants), pandemic and seasonal influenza, and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs with high barriers to resistance.

Nasdaq: COCP
IR Website:
Headquarters: Bothell, WA

Content provided by Cocrystal Pharma on 3/6/22.


The Cocrystal Pharma management team is always available to talk to current and potential investors. They're happy to answer any questions you may have and tell you what makes their story unique. Please fill out this form, and we will connect you shortly.


Investor Presentation

Management Overview

Risks & Disclosures